Global Hirudin Supply, Demand and Key Producers, 2024-2030

Global Hirudin Supply, Demand and Key Producers, 2024-2030

Page: 98

Published Date: 19 Feb 2024

Category: Chemical & Material

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global Hirudin market size is expected to reach $ 5018.9 million by 2030, rising at a market growth of 3.0% CAGR during the forecast period (2024-2030).

Global Hirudin key players include Pfizer, Teva Pharmaceutical, The Medicines Company, SALUBRIS, DUOPUTAI, etc. Global top five manufacturers hold a share about 20%. North America is the largest market, with a share about 30%, followed by Europe, with a share about 20 percent. In terms of product, Natural Hirudin is the largest segment, with a share about 55%. And in terms of application, the largest application is Thrombosis Disease, followed by Tumor Disease, etc.

This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.

This report studies the global Hirudin production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Hirudin, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Hirudin that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Hirudin total production and demand, 2019-2030, (K MT)
Global Hirudin total production value, 2019-2030, (USD Million)
Global Hirudin production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K MT)
Global Hirudin consumption by region & country, CAGR, 2019-2030 & (K MT)
U.S. VS China: Hirudin domestic production, consumption, key domestic manufacturers and share
Global Hirudin production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K MT)
Global Hirudin production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K MT)
Global Hirudin production by Application production, value, CAGR, 2019-2030, (USD Million) & (K MT).

This reports profiles key players in the global Hirudin market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include The Medicines Company, Keyken, Minapharm, Abbott, SALUBRIS, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, DUOPUTAI and Pentapharm, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Hirudin market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K MT) and average price (USD/MT) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Hirudin Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Hirudin Market, Segmentation by Type
Natural Hirudin
Recombinant Hirudin

Global Hirudin Market, Segmentation by Application
Thrombosis Disease
Tumor Disease
Others

Companies Profiled:
The Medicines Company
Keyken
Minapharm
Abbott
SALUBRIS
Pfizer, Inc
Teva Pharmaceutical Industries Ltd
DUOPUTAI
Pentapharm

Key Questions Answered
1. How big is the global Hirudin market?
2. What is the demand of the global Hirudin market?
3. What is the year over year growth of the global Hirudin market?
4. What is the production and production value of the global Hirudin market?
5. Who are the key producers in the global Hirudin market?
btl

Table of Contents

1 Supply Summary
1.1 Hirudin Introduction
1.2 World Hirudin Supply & Forecast
1.2.1 World Hirudin Production Value (2019 & 2023 & 2030)
1.2.2 World Hirudin Production (2019-2030)
1.2.3 World Hirudin Pricing Trends (2019-2030)
1.3 World Hirudin Production by Region (Based on Production Site)
1.3.1 World Hirudin Production Value by Region (2019-2030)
1.3.2 World Hirudin Production by Region (2019-2030)
1.3.3 World Hirudin Average Price by Region (2019-2030)
1.3.4 North America Hirudin Production (2019-2030)
1.3.5 Europe Hirudin Production (2019-2030)
1.3.6 China Hirudin Production (2019-2030)
1.3.7 Japan Hirudin Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Hirudin Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Hirudin Major Market Trends

2 Demand Summary
2.1 World Hirudin Demand (2019-2030)
2.2 World Hirudin Consumption by Region
2.2.1 World Hirudin Consumption by Region (2019-2024)
2.2.2 World Hirudin Consumption Forecast by Region (2025-2030)
2.3 United States Hirudin Consumption (2019-2030)
2.4 China Hirudin Consumption (2019-2030)
2.5 Europe Hirudin Consumption (2019-2030)
2.6 Japan Hirudin Consumption (2019-2030)
2.7 South Korea Hirudin Consumption (2019-2030)
2.8 ASEAN Hirudin Consumption (2019-2030)
2.9 India Hirudin Consumption (2019-2030)

3 World Hirudin Manufacturers Competitive Analysis
3.1 World Hirudin Production Value by Manufacturer (2019-2024)
3.2 World Hirudin Production by Manufacturer (2019-2024)
3.3 World Hirudin Average Price by Manufacturer (2019-2024)
3.4 Hirudin Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Hirudin Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Hirudin in 2023
3.5.3 Global Concentration Ratios (CR8) for Hirudin in 2023
3.6 Hirudin Market: Overall Company Footprint Analysis
3.6.1 Hirudin Market: Region Footprint
3.6.2 Hirudin Market: Company Product Type Footprint
3.6.3 Hirudin Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Hirudin Production Value Comparison
4.1.1 United States VS China: Hirudin Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Hirudin Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Hirudin Production Comparison
4.2.1 United States VS China: Hirudin Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Hirudin Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Hirudin Consumption Comparison
4.3.1 United States VS China: Hirudin Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Hirudin Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Hirudin Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Hirudin Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Hirudin Production Value (2019-2024)
4.4.3 United States Based Manufacturers Hirudin Production (2019-2024)
4.5 China Based Hirudin Manufacturers and Market Share
4.5.1 China Based Hirudin Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Hirudin Production Value (2019-2024)
4.5.3 China Based Manufacturers Hirudin Production (2019-2024)
4.6 Rest of World Based Hirudin Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Hirudin Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Hirudin Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Hirudin Production (2019-2024)

5 Market Analysis by Type
5.1 World Hirudin Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Natural Hirudin
5.2.2 Recombinant Hirudin
5.3 Market Segment by Type
5.3.1 World Hirudin Production by Type (2019-2030)
5.3.2 World Hirudin Production Value by Type (2019-2030)
5.3.3 World Hirudin Average Price by Type (2019-2030)

6 Market Analysis by Application
6.1 World Hirudin Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Thrombosis Disease
6.2.2 Tumor Disease
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Hirudin Production by Application (2019-2030)
6.3.2 World Hirudin Production Value by Application (2019-2030)
6.3.3 World Hirudin Average Price by Application (2019-2030)

7 Company Profiles
7.1 The Medicines Company
7.1.1 The Medicines Company Details
7.1.2 The Medicines Company Major Business
7.1.3 The Medicines Company Hirudin Product and Services
7.1.4 The Medicines Company Hirudin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 The Medicines Company Recent Developments/Updates
7.1.6 The Medicines Company Competitive Strengths & Weaknesses
7.2 Keyken
7.2.1 Keyken Details
7.2.2 Keyken Major Business
7.2.3 Keyken Hirudin Product and Services
7.2.4 Keyken Hirudin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Keyken Recent Developments/Updates
7.2.6 Keyken Competitive Strengths & Weaknesses
7.3 Minapharm
7.3.1 Minapharm Details
7.3.2 Minapharm Major Business
7.3.3 Minapharm Hirudin Product and Services
7.3.4 Minapharm Hirudin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Minapharm Recent Developments/Updates
7.3.6 Minapharm Competitive Strengths & Weaknesses
7.4 Abbott
7.4.1 Abbott Details
7.4.2 Abbott Major Business
7.4.3 Abbott Hirudin Product and Services
7.4.4 Abbott Hirudin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Abbott Recent Developments/Updates
7.4.6 Abbott Competitive Strengths & Weaknesses
7.5 SALUBRIS
7.5.1 SALUBRIS Details
7.5.2 SALUBRIS Major Business
7.5.3 SALUBRIS Hirudin Product and Services
7.5.4 SALUBRIS Hirudin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 SALUBRIS Recent Developments/Updates
7.5.6 SALUBRIS Competitive Strengths & Weaknesses
7.6 Pfizer, Inc
7.6.1 Pfizer, Inc Details
7.6.2 Pfizer, Inc Major Business
7.6.3 Pfizer, Inc Hirudin Product and Services
7.6.4 Pfizer, Inc Hirudin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Pfizer, Inc Recent Developments/Updates
7.6.6 Pfizer, Inc Competitive Strengths & Weaknesses
7.7 Teva Pharmaceutical Industries Ltd
7.7.1 Teva Pharmaceutical Industries Ltd Details
7.7.2 Teva Pharmaceutical Industries Ltd Major Business
7.7.3 Teva Pharmaceutical Industries Ltd Hirudin Product and Services
7.7.4 Teva Pharmaceutical Industries Ltd Hirudin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7.7.6 Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.8 DUOPUTAI
7.8.1 DUOPUTAI Details
7.8.2 DUOPUTAI Major Business
7.8.3 DUOPUTAI Hirudin Product and Services
7.8.4 DUOPUTAI Hirudin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 DUOPUTAI Recent Developments/Updates
7.8.6 DUOPUTAI Competitive Strengths & Weaknesses
7.9 Pentapharm
7.9.1 Pentapharm Details
7.9.2 Pentapharm Major Business
7.9.3 Pentapharm Hirudin Product and Services
7.9.4 Pentapharm Hirudin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Pentapharm Recent Developments/Updates
7.9.6 Pentapharm Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Hirudin Industry Chain
8.2 Hirudin Upstream Analysis
8.2.1 Hirudin Core Raw Materials
8.2.2 Main Manufacturers of Hirudin Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Hirudin Production Mode
8.6 Hirudin Procurement Model
8.7 Hirudin Industry Sales Model and Sales Channels
8.7.1 Hirudin Sales Model
8.7.2 Hirudin Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Hirudin Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Hirudin Production Value by Region (2019-2024) & (USD Million)
Table 3. World Hirudin Production Value by Region (2025-2030) & (USD Million)
Table 4. World Hirudin Production Value Market Share by Region (2019-2024)
Table 5. World Hirudin Production Value Market Share by Region (2025-2030)
Table 6. World Hirudin Production by Region (2019-2024) & (K MT)
Table 7. World Hirudin Production by Region (2025-2030) & (K MT)
Table 8. World Hirudin Production Market Share by Region (2019-2024)
Table 9. World Hirudin Production Market Share by Region (2025-2030)
Table 10. World Hirudin Average Price by Region (2019-2024) & (USD/MT)
Table 11. World Hirudin Average Price by Region (2025-2030) & (USD/MT)
Table 12. Hirudin Major Market Trends
Table 13. World Hirudin Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K MT)
Table 14. World Hirudin Consumption by Region (2019-2024) & (K MT)
Table 15. World Hirudin Consumption Forecast by Region (2025-2030) & (K MT)
Table 16. World Hirudin Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Hirudin Producers in 2023
Table 18. World Hirudin Production by Manufacturer (2019-2024) & (K MT)
Table 19. Production Market Share of Key Hirudin Producers in 2023
Table 20. World Hirudin Average Price by Manufacturer (2019-2024) & (USD/MT)
Table 21. Global Hirudin Company Evaluation Quadrant
Table 22. World Hirudin Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Hirudin Production Site of Key Manufacturer
Table 24. Hirudin Market: Company Product Type Footprint
Table 25. Hirudin Market: Company Product Application Footprint
Table 26. Hirudin Competitive Factors
Table 27. Hirudin New Entrant and Capacity Expansion Plans
Table 28. Hirudin Mergers & Acquisitions Activity
Table 29. United States VS China Hirudin Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Hirudin Production Comparison, (2019 & 2023 & 2030) & (K MT)
Table 31. United States VS China Hirudin Consumption Comparison, (2019 & 2023 & 2030) & (K MT)
Table 32. United States Based Hirudin Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Hirudin Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Hirudin Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Hirudin Production (2019-2024) & (K MT)
Table 36. United States Based Manufacturers Hirudin Production Market Share (2019-2024)
Table 37. China Based Hirudin Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Hirudin Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Hirudin Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Hirudin Production (2019-2024) & (K MT)
Table 41. China Based Manufacturers Hirudin Production Market Share (2019-2024)
Table 42. Rest of World Based Hirudin Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Hirudin Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Hirudin Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Hirudin Production (2019-2024) & (K MT)
Table 46. Rest of World Based Manufacturers Hirudin Production Market Share (2019-2024)
Table 47. World Hirudin Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Hirudin Production by Type (2019-2024) & (K MT)
Table 49. World Hirudin Production by Type (2025-2030) & (K MT)
Table 50. World Hirudin Production Value by Type (2019-2024) & (USD Million)
Table 51. World Hirudin Production Value by Type (2025-2030) & (USD Million)
Table 52. World Hirudin Average Price by Type (2019-2024) & (USD/MT)
Table 53. World Hirudin Average Price by Type (2025-2030) & (USD/MT)
Table 54. World Hirudin Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Hirudin Production by Application (2019-2024) & (K MT)
Table 56. World Hirudin Production by Application (2025-2030) & (K MT)
Table 57. World Hirudin Production Value by Application (2019-2024) & (USD Million)
Table 58. World Hirudin Production Value by Application (2025-2030) & (USD Million)
Table 59. World Hirudin Average Price by Application (2019-2024) & (USD/MT)
Table 60. World Hirudin Average Price by Application (2025-2030) & (USD/MT)
Table 61. The Medicines Company Basic Information, Manufacturing Base and Competitors
Table 62. The Medicines Company Major Business
Table 63. The Medicines Company Hirudin Product and Services
Table 64. The Medicines Company Hirudin Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. The Medicines Company Recent Developments/Updates
Table 66. The Medicines Company Competitive Strengths & Weaknesses
Table 67. Keyken Basic Information, Manufacturing Base and Competitors
Table 68. Keyken Major Business
Table 69. Keyken Hirudin Product and Services
Table 70. Keyken Hirudin Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Keyken Recent Developments/Updates
Table 72. Keyken Competitive Strengths & Weaknesses
Table 73. Minapharm Basic Information, Manufacturing Base and Competitors
Table 74. Minapharm Major Business
Table 75. Minapharm Hirudin Product and Services
Table 76. Minapharm Hirudin Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Minapharm Recent Developments/Updates
Table 78. Minapharm Competitive Strengths & Weaknesses
Table 79. Abbott Basic Information, Manufacturing Base and Competitors
Table 80. Abbott Major Business
Table 81. Abbott Hirudin Product and Services
Table 82. Abbott Hirudin Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Abbott Recent Developments/Updates
Table 84. Abbott Competitive Strengths & Weaknesses
Table 85. SALUBRIS Basic Information, Manufacturing Base and Competitors
Table 86. SALUBRIS Major Business
Table 87. SALUBRIS Hirudin Product and Services
Table 88. SALUBRIS Hirudin Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. SALUBRIS Recent Developments/Updates
Table 90. SALUBRIS Competitive Strengths & Weaknesses
Table 91. Pfizer, Inc Basic Information, Manufacturing Base and Competitors
Table 92. Pfizer, Inc Major Business
Table 93. Pfizer, Inc Hirudin Product and Services
Table 94. Pfizer, Inc Hirudin Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Pfizer, Inc Recent Developments/Updates
Table 96. Pfizer, Inc Competitive Strengths & Weaknesses
Table 97. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 98. Teva Pharmaceutical Industries Ltd Major Business
Table 99. Teva Pharmaceutical Industries Ltd Hirudin Product and Services
Table 100. Teva Pharmaceutical Industries Ltd Hirudin Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 102. Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 103. DUOPUTAI Basic Information, Manufacturing Base and Competitors
Table 104. DUOPUTAI Major Business
Table 105. DUOPUTAI Hirudin Product and Services
Table 106. DUOPUTAI Hirudin Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. DUOPUTAI Recent Developments/Updates
Table 108. Pentapharm Basic Information, Manufacturing Base and Competitors
Table 109. Pentapharm Major Business
Table 110. Pentapharm Hirudin Product and Services
Table 111. Pentapharm Hirudin Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 112. Global Key Players of Hirudin Upstream (Raw Materials)
Table 113. Hirudin Typical Customers
Table 114. Hirudin Typical Distributors
List of Figure
Figure 1. Hirudin Picture
Figure 2. World Hirudin Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Hirudin Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Hirudin Production (2019-2030) & (K MT)
Figure 5. World Hirudin Average Price (2019-2030) & (USD/MT)
Figure 6. World Hirudin Production Value Market Share by Region (2019-2030)
Figure 7. World Hirudin Production Market Share by Region (2019-2030)
Figure 8. North America Hirudin Production (2019-2030) & (K MT)
Figure 9. Europe Hirudin Production (2019-2030) & (K MT)
Figure 10. China Hirudin Production (2019-2030) & (K MT)
Figure 11. Japan Hirudin Production (2019-2030) & (K MT)
Figure 12. Hirudin Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Hirudin Consumption (2019-2030) & (K MT)
Figure 15. World Hirudin Consumption Market Share by Region (2019-2030)
Figure 16. United States Hirudin Consumption (2019-2030) & (K MT)
Figure 17. China Hirudin Consumption (2019-2030) & (K MT)
Figure 18. Europe Hirudin Consumption (2019-2030) & (K MT)
Figure 19. Japan Hirudin Consumption (2019-2030) & (K MT)
Figure 20. South Korea Hirudin Consumption (2019-2030) & (K MT)
Figure 21. ASEAN Hirudin Consumption (2019-2030) & (K MT)
Figure 22. India Hirudin Consumption (2019-2030) & (K MT)
Figure 23. Producer Shipments of Hirudin by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Hirudin Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Hirudin Markets in 2023
Figure 26. United States VS China: Hirudin Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Hirudin Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Hirudin Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Hirudin Production Market Share 2023
Figure 30. China Based Manufacturers Hirudin Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Hirudin Production Market Share 2023
Figure 32. World Hirudin Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Hirudin Production Value Market Share by Type in 2023
Figure 34. Natural Hirudin
Figure 35. Recombinant Hirudin
Figure 36. World Hirudin Production Market Share by Type (2019-2030)
Figure 37. World Hirudin Production Value Market Share by Type (2019-2030)
Figure 38. World Hirudin Average Price by Type (2019-2030) & (USD/MT)
Figure 39. World Hirudin Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 40. World Hirudin Production Value Market Share by Application in 2023
Figure 41. Thrombosis Disease
Figure 42. Tumor Disease
Figure 43. Others
Figure 44. World Hirudin Production Market Share by Application (2019-2030)
Figure 45. World Hirudin Production Value Market Share by Application (2019-2030)
Figure 46. World Hirudin Average Price by Application (2019-2030) & (USD/MT)
Figure 47. Hirudin Industry Chain
Figure 48. Hirudin Procurement Model
Figure 49. Hirudin Sales Model
Figure 50. Hirudin Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

The Medicines Company
Keyken
Minapharm
Abbott
SALUBRIS
Pfizer, Inc
Teva Pharmaceutical Industries Ltd
DUOPUTAI
Pentapharm
btl

Related Reports

Global Hirudin Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029 xian22

Global Hirudin Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Chemical & Material

This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Hirudin Supply, Demand and Key Producers, 2024-2030

Global Hirudin Supply, Demand and Key Producers, 2024-2030

Page: 98

Published Date: 19 Feb 2024

Category: Chemical & Material

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global Hirudin market size is expected to reach $ 5018.9 million by 2030, rising at a market growth of 3.0% CAGR during the forecast period (2024-2030).

Global Hirudin key players include Pfizer, Teva Pharmaceutical, The Medicines Company, SALUBRIS, DUOPUTAI, etc. Global top five manufacturers hold a share about 20%. North America is the largest market, with a share about 30%, followed by Europe, with a share about 20 percent. In terms of product, Natural Hirudin is the largest segment, with a share about 55%. And in terms of application, the largest application is Thrombosis Disease, followed by Tumor Disease, etc.

This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.

This report studies the global Hirudin production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Hirudin, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Hirudin that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Hirudin total production and demand, 2019-2030, (K MT)
Global Hirudin total production value, 2019-2030, (USD Million)
Global Hirudin production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K MT)
Global Hirudin consumption by region & country, CAGR, 2019-2030 & (K MT)
U.S. VS China: Hirudin domestic production, consumption, key domestic manufacturers and share
Global Hirudin production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K MT)
Global Hirudin production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K MT)
Global Hirudin production by Application production, value, CAGR, 2019-2030, (USD Million) & (K MT).

This reports profiles key players in the global Hirudin market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include The Medicines Company, Keyken, Minapharm, Abbott, SALUBRIS, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, DUOPUTAI and Pentapharm, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Hirudin market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K MT) and average price (USD/MT) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Hirudin Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Hirudin Market, Segmentation by Type
Natural Hirudin
Recombinant Hirudin

Global Hirudin Market, Segmentation by Application
Thrombosis Disease
Tumor Disease
Others

Companies Profiled:
The Medicines Company
Keyken
Minapharm
Abbott
SALUBRIS
Pfizer, Inc
Teva Pharmaceutical Industries Ltd
DUOPUTAI
Pentapharm

Key Questions Answered
1. How big is the global Hirudin market?
2. What is the demand of the global Hirudin market?
3. What is the year over year growth of the global Hirudin market?
4. What is the production and production value of the global Hirudin market?
5. Who are the key producers in the global Hirudin market?
btl

Table of Contents

1 Supply Summary
1.1 Hirudin Introduction
1.2 World Hirudin Supply & Forecast
1.2.1 World Hirudin Production Value (2019 & 2023 & 2030)
1.2.2 World Hirudin Production (2019-2030)
1.2.3 World Hirudin Pricing Trends (2019-2030)
1.3 World Hirudin Production by Region (Based on Production Site)
1.3.1 World Hirudin Production Value by Region (2019-2030)
1.3.2 World Hirudin Production by Region (2019-2030)
1.3.3 World Hirudin Average Price by Region (2019-2030)
1.3.4 North America Hirudin Production (2019-2030)
1.3.5 Europe Hirudin Production (2019-2030)
1.3.6 China Hirudin Production (2019-2030)
1.3.7 Japan Hirudin Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Hirudin Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Hirudin Major Market Trends

2 Demand Summary
2.1 World Hirudin Demand (2019-2030)
2.2 World Hirudin Consumption by Region
2.2.1 World Hirudin Consumption by Region (2019-2024)
2.2.2 World Hirudin Consumption Forecast by Region (2025-2030)
2.3 United States Hirudin Consumption (2019-2030)
2.4 China Hirudin Consumption (2019-2030)
2.5 Europe Hirudin Consumption (2019-2030)
2.6 Japan Hirudin Consumption (2019-2030)
2.7 South Korea Hirudin Consumption (2019-2030)
2.8 ASEAN Hirudin Consumption (2019-2030)
2.9 India Hirudin Consumption (2019-2030)

3 World Hirudin Manufacturers Competitive Analysis
3.1 World Hirudin Production Value by Manufacturer (2019-2024)
3.2 World Hirudin Production by Manufacturer (2019-2024)
3.3 World Hirudin Average Price by Manufacturer (2019-2024)
3.4 Hirudin Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Hirudin Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Hirudin in 2023
3.5.3 Global Concentration Ratios (CR8) for Hirudin in 2023
3.6 Hirudin Market: Overall Company Footprint Analysis
3.6.1 Hirudin Market: Region Footprint
3.6.2 Hirudin Market: Company Product Type Footprint
3.6.3 Hirudin Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Hirudin Production Value Comparison
4.1.1 United States VS China: Hirudin Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Hirudin Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Hirudin Production Comparison
4.2.1 United States VS China: Hirudin Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Hirudin Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Hirudin Consumption Comparison
4.3.1 United States VS China: Hirudin Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Hirudin Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Hirudin Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Hirudin Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Hirudin Production Value (2019-2024)
4.4.3 United States Based Manufacturers Hirudin Production (2019-2024)
4.5 China Based Hirudin Manufacturers and Market Share
4.5.1 China Based Hirudin Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Hirudin Production Value (2019-2024)
4.5.3 China Based Manufacturers Hirudin Production (2019-2024)
4.6 Rest of World Based Hirudin Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Hirudin Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Hirudin Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Hirudin Production (2019-2024)

5 Market Analysis by Type
5.1 World Hirudin Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Natural Hirudin
5.2.2 Recombinant Hirudin
5.3 Market Segment by Type
5.3.1 World Hirudin Production by Type (2019-2030)
5.3.2 World Hirudin Production Value by Type (2019-2030)
5.3.3 World Hirudin Average Price by Type (2019-2030)

6 Market Analysis by Application
6.1 World Hirudin Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Thrombosis Disease
6.2.2 Tumor Disease
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Hirudin Production by Application (2019-2030)
6.3.2 World Hirudin Production Value by Application (2019-2030)
6.3.3 World Hirudin Average Price by Application (2019-2030)

7 Company Profiles
7.1 The Medicines Company
7.1.1 The Medicines Company Details
7.1.2 The Medicines Company Major Business
7.1.3 The Medicines Company Hirudin Product and Services
7.1.4 The Medicines Company Hirudin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 The Medicines Company Recent Developments/Updates
7.1.6 The Medicines Company Competitive Strengths & Weaknesses
7.2 Keyken
7.2.1 Keyken Details
7.2.2 Keyken Major Business
7.2.3 Keyken Hirudin Product and Services
7.2.4 Keyken Hirudin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Keyken Recent Developments/Updates
7.2.6 Keyken Competitive Strengths & Weaknesses
7.3 Minapharm
7.3.1 Minapharm Details
7.3.2 Minapharm Major Business
7.3.3 Minapharm Hirudin Product and Services
7.3.4 Minapharm Hirudin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Minapharm Recent Developments/Updates
7.3.6 Minapharm Competitive Strengths & Weaknesses
7.4 Abbott
7.4.1 Abbott Details
7.4.2 Abbott Major Business
7.4.3 Abbott Hirudin Product and Services
7.4.4 Abbott Hirudin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Abbott Recent Developments/Updates
7.4.6 Abbott Competitive Strengths & Weaknesses
7.5 SALUBRIS
7.5.1 SALUBRIS Details
7.5.2 SALUBRIS Major Business
7.5.3 SALUBRIS Hirudin Product and Services
7.5.4 SALUBRIS Hirudin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 SALUBRIS Recent Developments/Updates
7.5.6 SALUBRIS Competitive Strengths & Weaknesses
7.6 Pfizer, Inc
7.6.1 Pfizer, Inc Details
7.6.2 Pfizer, Inc Major Business
7.6.3 Pfizer, Inc Hirudin Product and Services
7.6.4 Pfizer, Inc Hirudin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Pfizer, Inc Recent Developments/Updates
7.6.6 Pfizer, Inc Competitive Strengths & Weaknesses
7.7 Teva Pharmaceutical Industries Ltd
7.7.1 Teva Pharmaceutical Industries Ltd Details
7.7.2 Teva Pharmaceutical Industries Ltd Major Business
7.7.3 Teva Pharmaceutical Industries Ltd Hirudin Product and Services
7.7.4 Teva Pharmaceutical Industries Ltd Hirudin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7.7.6 Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.8 DUOPUTAI
7.8.1 DUOPUTAI Details
7.8.2 DUOPUTAI Major Business
7.8.3 DUOPUTAI Hirudin Product and Services
7.8.4 DUOPUTAI Hirudin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 DUOPUTAI Recent Developments/Updates
7.8.6 DUOPUTAI Competitive Strengths & Weaknesses
7.9 Pentapharm
7.9.1 Pentapharm Details
7.9.2 Pentapharm Major Business
7.9.3 Pentapharm Hirudin Product and Services
7.9.4 Pentapharm Hirudin Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Pentapharm Recent Developments/Updates
7.9.6 Pentapharm Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Hirudin Industry Chain
8.2 Hirudin Upstream Analysis
8.2.1 Hirudin Core Raw Materials
8.2.2 Main Manufacturers of Hirudin Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Hirudin Production Mode
8.6 Hirudin Procurement Model
8.7 Hirudin Industry Sales Model and Sales Channels
8.7.1 Hirudin Sales Model
8.7.2 Hirudin Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Hirudin Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Hirudin Production Value by Region (2019-2024) & (USD Million)
Table 3. World Hirudin Production Value by Region (2025-2030) & (USD Million)
Table 4. World Hirudin Production Value Market Share by Region (2019-2024)
Table 5. World Hirudin Production Value Market Share by Region (2025-2030)
Table 6. World Hirudin Production by Region (2019-2024) & (K MT)
Table 7. World Hirudin Production by Region (2025-2030) & (K MT)
Table 8. World Hirudin Production Market Share by Region (2019-2024)
Table 9. World Hirudin Production Market Share by Region (2025-2030)
Table 10. World Hirudin Average Price by Region (2019-2024) & (USD/MT)
Table 11. World Hirudin Average Price by Region (2025-2030) & (USD/MT)
Table 12. Hirudin Major Market Trends
Table 13. World Hirudin Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K MT)
Table 14. World Hirudin Consumption by Region (2019-2024) & (K MT)
Table 15. World Hirudin Consumption Forecast by Region (2025-2030) & (K MT)
Table 16. World Hirudin Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Hirudin Producers in 2023
Table 18. World Hirudin Production by Manufacturer (2019-2024) & (K MT)
Table 19. Production Market Share of Key Hirudin Producers in 2023
Table 20. World Hirudin Average Price by Manufacturer (2019-2024) & (USD/MT)
Table 21. Global Hirudin Company Evaluation Quadrant
Table 22. World Hirudin Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Hirudin Production Site of Key Manufacturer
Table 24. Hirudin Market: Company Product Type Footprint
Table 25. Hirudin Market: Company Product Application Footprint
Table 26. Hirudin Competitive Factors
Table 27. Hirudin New Entrant and Capacity Expansion Plans
Table 28. Hirudin Mergers & Acquisitions Activity
Table 29. United States VS China Hirudin Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Hirudin Production Comparison, (2019 & 2023 & 2030) & (K MT)
Table 31. United States VS China Hirudin Consumption Comparison, (2019 & 2023 & 2030) & (K MT)
Table 32. United States Based Hirudin Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Hirudin Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Hirudin Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Hirudin Production (2019-2024) & (K MT)
Table 36. United States Based Manufacturers Hirudin Production Market Share (2019-2024)
Table 37. China Based Hirudin Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Hirudin Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Hirudin Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Hirudin Production (2019-2024) & (K MT)
Table 41. China Based Manufacturers Hirudin Production Market Share (2019-2024)
Table 42. Rest of World Based Hirudin Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Hirudin Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Hirudin Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Hirudin Production (2019-2024) & (K MT)
Table 46. Rest of World Based Manufacturers Hirudin Production Market Share (2019-2024)
Table 47. World Hirudin Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Hirudin Production by Type (2019-2024) & (K MT)
Table 49. World Hirudin Production by Type (2025-2030) & (K MT)
Table 50. World Hirudin Production Value by Type (2019-2024) & (USD Million)
Table 51. World Hirudin Production Value by Type (2025-2030) & (USD Million)
Table 52. World Hirudin Average Price by Type (2019-2024) & (USD/MT)
Table 53. World Hirudin Average Price by Type (2025-2030) & (USD/MT)
Table 54. World Hirudin Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Hirudin Production by Application (2019-2024) & (K MT)
Table 56. World Hirudin Production by Application (2025-2030) & (K MT)
Table 57. World Hirudin Production Value by Application (2019-2024) & (USD Million)
Table 58. World Hirudin Production Value by Application (2025-2030) & (USD Million)
Table 59. World Hirudin Average Price by Application (2019-2024) & (USD/MT)
Table 60. World Hirudin Average Price by Application (2025-2030) & (USD/MT)
Table 61. The Medicines Company Basic Information, Manufacturing Base and Competitors
Table 62. The Medicines Company Major Business
Table 63. The Medicines Company Hirudin Product and Services
Table 64. The Medicines Company Hirudin Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. The Medicines Company Recent Developments/Updates
Table 66. The Medicines Company Competitive Strengths & Weaknesses
Table 67. Keyken Basic Information, Manufacturing Base and Competitors
Table 68. Keyken Major Business
Table 69. Keyken Hirudin Product and Services
Table 70. Keyken Hirudin Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Keyken Recent Developments/Updates
Table 72. Keyken Competitive Strengths & Weaknesses
Table 73. Minapharm Basic Information, Manufacturing Base and Competitors
Table 74. Minapharm Major Business
Table 75. Minapharm Hirudin Product and Services
Table 76. Minapharm Hirudin Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Minapharm Recent Developments/Updates
Table 78. Minapharm Competitive Strengths & Weaknesses
Table 79. Abbott Basic Information, Manufacturing Base and Competitors
Table 80. Abbott Major Business
Table 81. Abbott Hirudin Product and Services
Table 82. Abbott Hirudin Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Abbott Recent Developments/Updates
Table 84. Abbott Competitive Strengths & Weaknesses
Table 85. SALUBRIS Basic Information, Manufacturing Base and Competitors
Table 86. SALUBRIS Major Business
Table 87. SALUBRIS Hirudin Product and Services
Table 88. SALUBRIS Hirudin Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. SALUBRIS Recent Developments/Updates
Table 90. SALUBRIS Competitive Strengths & Weaknesses
Table 91. Pfizer, Inc Basic Information, Manufacturing Base and Competitors
Table 92. Pfizer, Inc Major Business
Table 93. Pfizer, Inc Hirudin Product and Services
Table 94. Pfizer, Inc Hirudin Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Pfizer, Inc Recent Developments/Updates
Table 96. Pfizer, Inc Competitive Strengths & Weaknesses
Table 97. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 98. Teva Pharmaceutical Industries Ltd Major Business
Table 99. Teva Pharmaceutical Industries Ltd Hirudin Product and Services
Table 100. Teva Pharmaceutical Industries Ltd Hirudin Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 102. Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 103. DUOPUTAI Basic Information, Manufacturing Base and Competitors
Table 104. DUOPUTAI Major Business
Table 105. DUOPUTAI Hirudin Product and Services
Table 106. DUOPUTAI Hirudin Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. DUOPUTAI Recent Developments/Updates
Table 108. Pentapharm Basic Information, Manufacturing Base and Competitors
Table 109. Pentapharm Major Business
Table 110. Pentapharm Hirudin Product and Services
Table 111. Pentapharm Hirudin Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 112. Global Key Players of Hirudin Upstream (Raw Materials)
Table 113. Hirudin Typical Customers
Table 114. Hirudin Typical Distributors
List of Figure
Figure 1. Hirudin Picture
Figure 2. World Hirudin Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Hirudin Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Hirudin Production (2019-2030) & (K MT)
Figure 5. World Hirudin Average Price (2019-2030) & (USD/MT)
Figure 6. World Hirudin Production Value Market Share by Region (2019-2030)
Figure 7. World Hirudin Production Market Share by Region (2019-2030)
Figure 8. North America Hirudin Production (2019-2030) & (K MT)
Figure 9. Europe Hirudin Production (2019-2030) & (K MT)
Figure 10. China Hirudin Production (2019-2030) & (K MT)
Figure 11. Japan Hirudin Production (2019-2030) & (K MT)
Figure 12. Hirudin Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Hirudin Consumption (2019-2030) & (K MT)
Figure 15. World Hirudin Consumption Market Share by Region (2019-2030)
Figure 16. United States Hirudin Consumption (2019-2030) & (K MT)
Figure 17. China Hirudin Consumption (2019-2030) & (K MT)
Figure 18. Europe Hirudin Consumption (2019-2030) & (K MT)
Figure 19. Japan Hirudin Consumption (2019-2030) & (K MT)
Figure 20. South Korea Hirudin Consumption (2019-2030) & (K MT)
Figure 21. ASEAN Hirudin Consumption (2019-2030) & (K MT)
Figure 22. India Hirudin Consumption (2019-2030) & (K MT)
Figure 23. Producer Shipments of Hirudin by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Hirudin Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Hirudin Markets in 2023
Figure 26. United States VS China: Hirudin Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Hirudin Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Hirudin Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Hirudin Production Market Share 2023
Figure 30. China Based Manufacturers Hirudin Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Hirudin Production Market Share 2023
Figure 32. World Hirudin Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Hirudin Production Value Market Share by Type in 2023
Figure 34. Natural Hirudin
Figure 35. Recombinant Hirudin
Figure 36. World Hirudin Production Market Share by Type (2019-2030)
Figure 37. World Hirudin Production Value Market Share by Type (2019-2030)
Figure 38. World Hirudin Average Price by Type (2019-2030) & (USD/MT)
Figure 39. World Hirudin Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 40. World Hirudin Production Value Market Share by Application in 2023
Figure 41. Thrombosis Disease
Figure 42. Tumor Disease
Figure 43. Others
Figure 44. World Hirudin Production Market Share by Application (2019-2030)
Figure 45. World Hirudin Production Value Market Share by Application (2019-2030)
Figure 46. World Hirudin Average Price by Application (2019-2030) & (USD/MT)
Figure 47. Hirudin Industry Chain
Figure 48. Hirudin Procurement Model
Figure 49. Hirudin Sales Model
Figure 50. Hirudin Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

The Medicines Company
Keyken
Minapharm
Abbott
SALUBRIS
Pfizer, Inc
Teva Pharmaceutical Industries Ltd
DUOPUTAI
Pentapharm
btl

Related Reports

Global Hirudin Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029 xian22
q3

Global Hirudin Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

industry 18 Mar 2023

industry Chemical & Material

This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.

jiaGou

Add To Cart

gouMai

Buy Now